Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 15547830 | HLA-DR (HLA-DR) | jaundice | NA | NA | NA | only_studied | |
| liver biopsy specimens from patients with ba (n = 14) and normal liver biopsies (n = 12) were studied immunohistochemically and were assessed immune electron microscopically to detect the expression of hla-dr. all patients underwent follow-up for at least 3 months after surgery evaluating the short-term postoperative outcome by monitoring the serum bilirubin level during jaundice persistency. | |||||||
| 15547830 | HLA-DR (HLA-DR) | biliary atresia | NA | NA | NA | unclassified | |
| the aberrant expression of hla-dr in intrahepatic bile ducts in patients with biliary atresia: an immunohistochemistry and immune electron microscopy study. | |||||||
| 23587473 | HLA (HLA) | ribavirin | NA | hepatitis | rs12979860 | negation | |
| NA | |||||||
| 3863585 | HLA (HLA) | fetal growth retardation | NA | NA | NA | unclassified | |
| hla a and b types of the mother, father and infant were determined in 30 pregnancies complicated by intrauterine fetal growth retardation (iugr) and in 32 normal pregnancies. | |||||||
| 8138977 | HLA (HLA) | oral submucous fibrosis | Indian | NA | NA | unclassified | |
| hla-antigens in oral submucous fibrosis. | |||||||
| 8138977 | HLA ASSOCIATED (HLA-ASSOCIATED) | oral submucous fibrosis | Indian | NA | NA | negation | |
| it is concluded that there is not necessarily a hla-associated susceptibility in oral submucous fibrosis. | |||||||
| 15061705 | HLA (HLA) | oral submucous fibrosis | Taiwanese | NA | NA | unclassified | |
| hla typing in taiwanese patients with oral submucous fibrosis. | |||||||
| 15061705 | HLA (HLA) | oral submucous fibrosis | Taiwanese | NA | NA | positive | |
| a significant association of certain human leukocyte antigens (hla) and haplotypic pairs with oral submucous fibrosis (osf) has been reported. | |||||||
| 3872164 | HLA-DR (HLA-DR) | b cell leukemia | NA | NA | NA | unclassified | |
| marker studies of marrow blasts show an unusual and possibly unique pattern, in that an unequivocal monoclonal b cell leukemia, having k-igm with hla-dr and b cell subset antigen (ba-1) expression, was superimposed with a mature suppressor t cell marker profile (pan-t, mature t, and suppressor/cytotoxic t antigens). | |||||||
| 8315353 | HLA-DQB1 (HLA-DQB1) | b cell leukemia | NA | NA | NA | negation | |
| we investigated the differential expression of the hla-dqb gene, using b cell lines laz221 and laz388: laz221, derived from an early b cell leukemia, expresses hla-dr but not hla-dq: laz388, the autologous epstein-barr virus-transformed b cell line, expresses both dr and dq. | |||||||
Copyright 2024